Zukowska-Szczechowska E, Grzeszczak W, Kokot F
Katedry i Kliniki Nefrologii Slaskiej Akademii Medycznej, Katowicach.
Pol Arch Med Wewn. 1992 Nov;88(5):324-9.
Function of the renin-angiotensin-aldosterone (RAA) system in kidney transplant patients (KTP) is often abnormal as in patients with chronic renal failure. On the other hand the importance of opioids in the regulation of function of endocrine organs is well established. These facts were the background of studies presented in this paper. They aimed to assess the role of opioid receptors in the regulation of the RAA in KTP. 12 patients with a stabilized renal graft function and on cyclosporin A + prednisone therapy and 15 healthy subjects were examined. In all subjects plasma renin activity (PRA), plasma aldosterone level (Ald) and blood pressure were assessed during a 4 hr bed-rest test. In each subject two tests were performed: the first one without naloxone administration, and the second one--after opioid receptor blockade. In KTP significantly elevated PRA and blood pressure and moderately elevated plasma Ald levels were found as compared with normals. After a 4 hr bed rest without naloxone no significant changes of the above mentioned parameters were noticed both in the patients and the controls. After opioid receptors blockade by naloxone a significant decrease of PRA and plasma Ald was observed in both examined groups. This decrease was significantly more marked in KTP than in controls. In addition only in KTP 4 hrs after naloxone administration a significant increase of systolic and diastolic blood pressure was found. Results obtained in this study suggest, that opioid receptors are involved in the regulation of the activity of the RAA system and of blood pressure more markedly in KTP than in healthy subjects.
肾素 - 血管紧张素 - 醛固酮(RAA)系统在肾移植患者(KTP)中的功能通常与慢性肾衰竭患者一样异常。另一方面,阿片类物质在内分泌器官功能调节中的重要性已得到充分证实。这些事实是本文所呈现研究的背景。这些研究旨在评估阿片受体在肾移植患者中对RAA系统调节的作用。对12名肾移植功能稳定且正在接受环孢素A加泼尼松治疗的患者以及15名健康受试者进行了检查。在所有受试者中,在4小时卧床休息试验期间评估血浆肾素活性(PRA)、血浆醛固酮水平(Ald)和血压。对每个受试者进行两项测试:第一项在不给予纳洛酮的情况下进行,第二项在阿片受体阻断后进行。与正常人相比,肾移植患者中发现PRA和血压显著升高,血浆Ald水平中度升高。在不给予纳洛酮的情况下进行4小时卧床休息后,患者和对照组上述参数均未发现显著变化。在给予纳洛酮阻断阿片受体后,两个检查组的PRA和血浆Ald均显著降低。这种降低在肾移植患者中比在对照组中更为明显。此外,仅在肾移植患者中,给予纳洛酮4小时后发现收缩压和舒张压显著升高。本研究获得的结果表明,阿片受体参与了RAA系统活性和血压的调节,且在肾移植患者中比在健康受试者中更为明显。